Drug Topics
FEBRUARY 22, 2024
On January 6, 2023, the FDA granted lecanemab-irmb (Leqembi) accelerated approval for treating mild cognitive impairment and mild dementia in patients with Alzheimer disease.
Pharmacy Is Right For Me
FEBRUARY 22, 2024
There is a common misconception that all community pharmacies are alike, and that most of what community pharmacists do is count pills. This could not be further from the truth and Dr. Mohanad Znbaqa’s story will demonstrate just how versatile a career practicing in a community pharmacy can be! Expanding Horizons: A Pharmacist’s Journey in Ambulatory Care Dr.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
FEBRUARY 22, 2024
Patients and other stakeholders need to be able to compare pharmacies based on standardized, transparent metrics with a measurement system to make informed decisions.
Drug Topics
FEBRUARY 22, 2024
Study results suggesting that long-term cumulative use of attention-deficit/hyperactivity disorder (ADHD) medication increases the risk of CVD could prompt potential adjustments in treatment approaches for ADHD.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
FEBRUARY 22, 2024
A Florida state policy set amid a measles outbreak in Broward County has vaccination proponents aghast, with many saying it leaves unvaccinated children especially vulnerable to the highly contagious disease. In a letter dated Tuesday about an outbreak at Manatee Bay Elementary School in Weston, located northwest of Miami and west of Fort Lauderdale, the state’s surgeon general, Joseph Ladapo, said that while it is normal policy to tell unvaccinated children to stay home during an outbrea
Fierce Healthcare
FEBRUARY 22, 2024
Investors continue to pour money into generative AI startups and Abridge is riding this wave as it rapidly scales its technology across U.S. health systems. | Along with the funding round, Abridge also announced an enterprise agreement with Connecticut-based Yale New Haven Health System to give thousands of clinicians access to its AI-powered clinical documentation technology.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Fierce Healthcare
FEBRUARY 22, 2024
Change Healthcare is mitigating a "cybersecurity issue" that began Wednesday, and details remain scant. | Change Healthcare is mitigating a "cybersecurity issue" that began Wednesday, and details remain scant.
STAT
FEBRUARY 22, 2024
Imagine having 15 miscarriages. Maybe you can shrug off the first one or two and keep trying to have children, to create a family. But soon every positive pregnancy test brings a sense of dread, of sad inevitability. Your body becomes your enemy.
Fierce Healthcare
FEBRUARY 22, 2024
Fourteen organizations representing providers, payers, consumer technology companies and employers are teaming up to cut through the noise and raise higher standards for finding digital health | Fourteen organizations representing providers, payers, consumer technology companies and employers are teaming up to cut through the noise and raise higher standards for finding digital health solutions that work and are worth the investment.
STAT
FEBRUARY 22, 2024
In the years leading up to Russia’s invasion, Ukraine had become a burgeoning hub of clinical trials, particularly in oncology. The war put a hold on the vast majority of those studies. But as the country marks two years this week since the invasion — and as the war has dragged on without a clear end in sight — Ukrainian researchers and executives are increasingly urging companies to restart clinical trials, insisting that the advantages that lured drugmakers in the first pl
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
FEBRUARY 22, 2024
Currently, the safety and efficacy of linvoseltamab in adult patients with relapsed or refractory multiple myeloma is being compared to elotuzumab, pomalidomide, and dexamethasone in a phase 3 clinical trial.
STAT
FEBRUARY 22, 2024
An embryo is one of the earliest stages of development of a multicellular organism. But according to the Supreme Court of Alabama, it is a person, too — an unborn child, entitled to the same legal protections as any minor. The court ruled on Feb. 16 that a fertility clinic patient who accidentally destroyed other patients’ frozen embryos could be liable in a wrongful death lawsuit, writing in its opinion that “the Wrongful Death of a Minor Act applies to all unborn children,
Pharmacy Times
FEBRUARY 22, 2024
The practice could become routine if parents promote morning vegetable consumption while the children are still in a developmental stage of life.
STAT
FEBRUARY 22, 2024
The U.S. Food and Drug Administration told an advocacy group that it is not planning to take a tougher stance against wayward clinical trial sponsors and investigators that fail to register studies or report results, a central issue in the ongoing debate over greater transparency into clinical research. In response to a citizen’s petition filed a year ago, the agency indicated it is unlikely to levy fines or take a more stringent approach to issue so-called non-compliance notices because
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Healthcare
FEBRUARY 22, 2024
Fans of healthcare price transparency and Grammy Award-winning bands should have their calendars marked for March 5 in Washington, D.C. | The Foo Fighters are joining the fight against price transparency with an upcoming, private concert in Washington, D.C., on behalf of advocacy group Power to the Patients.
STAT
FEBRUARY 22, 2024
Community Health Systems is facing a new federal probe into its hospital billing practices more than four years after the hospital chain settled separate allegations of fraudulent overbilling. CHS, a national system of 71 rural and suburban hospitals, said this week it received a civil investigative demand from the Department of Justice on Jan. 11. Federal investigators asked CHS to hand over documents that covered “practices and procedures related to utilization review, inpatient admissi
Fierce Pharma
FEBRUARY 22, 2024
As Roche officially abandoned cancer drug Gavreto, its former partner Blueprint Medicines has found the RET inhibitor a new owner in the U.S. | As Roche officially abandoned cancer drug Gavreto, its former partner Blueprint Medicines has found the RET inhibitor a new U.S. owner in Rigel Pharmaceuticals.
STAT
FEBRUARY 22, 2024
After a contentious dispute, Novavax has agreed to refund up to $400 million to the international organization that purchased Covid-19 shots as part of a global vaccination program, but found itself with vaccines that were no longer needed. The agreement caps a disconcerting episode involving several vaccine makers and Gavi, the Vaccine Alliance, a public-private partnership that worked with the World Health Organization as the Covid-19 pandemic erupted four years ago to bring Covid shots to low
pharmaphorum
FEBRUARY 22, 2024
Discover how AI, automation, and blockchain technologies are revolutionising pharmaceutical case processing in compliance with FDA regulations. Explore the benefits of these advancements in this insightful article.
STAT
FEBRUARY 22, 2024
A Pittsburgh artificial intelligence startup emerging as a challenger to Microsoft’s clinical note taking business has raised $150 million, a rare mega deal in a funding lull. The startup, Abridge, also has an unlikely cheerleader: Paul Ricci, the former head of Nuance, the service from Microsoft it competes with. Abridge sells an AI tool that rapidly transcribes and summarizes doctors’ conversations with patients in a hospital’s electronic health records software.
pharmaphorum
FEBRUARY 22, 2024
On today’s episode of the pharmaphorum podcast, Jason Park, CEO of Empress Therapeutics, discusses his company's novel approach to small molecule drug discovery.
STAT
FEBRUARY 22, 2024
One of us, Jeffrey M., is on weekend call for our office-based internal medicine practice. It is midafternoon, and a patient leaves a message with our answering service — she is concerned about her mother’s respiratory symptoms. So, Jeffrey interrupts his late lunch and rings her back. As she explains that her 96-year-old mother has a harsh cough and nasal congestion, he hears both the facts and the worry in her voice.
Pharmacy Times
FEBRUARY 22, 2024
These experiences can impact mental health, which can mediate parenting behaviors like inconsistent discipline.
pharmaphorum
FEBRUARY 22, 2024
In a dynamic healthcare market, securing top talent is essential for the success of any organisation. Advanced Clinical looks at innovative recruitment strategies and solutions to help you attract and retain the best healthcare professionals.
Hospital Pharmacy Europe
FEBRUARY 22, 2024
Pharmacogenetics is increasingly seen as an essential tool in drug therapy and medicines optimisation. As evidence accumulates to support its use in clinical practice, pharmacists must have the requisite knowledge and skills to support and lead in implementing pharmacogenetics as part of routine healthcare. Ben McIntyre, Jessica Keen and Dr John McDermott outline the fundamental concepts and describe how pharmacogenetics is being implemented in practice.
Drug Store News
FEBRUARY 22, 2024
The ‘It Means More’ ad spotlights its commitment to customers, together with the passion and ongoing dedication of its employees to continuously provide unrivaled customer experiences.
Fierce Healthcare
FEBRUARY 22, 2024
Digital chronic condition management company DarioHealth is buying Twill to expand its capabilities into mental health and boost revenue. | Digital chronic condition management company DarioHealth is buying Twill to expand its capabilities into mental health and boost revenue.
Drug Store News
FEBRUARY 22, 2024
Lay’s Sweet & Spicy Honey flavored chips are making their debut with a campaign starring reality television stars Cameron Hamilton and Lauren Speed-Hamilton from Netflix’s “Love Is Blind.
pharmaphorum
FEBRUARY 22, 2024
Stay updated on the latest clinical trials happening from 29th January to 2nd February 2024. Explore trials by Vidac, Orion, Revolo Biotherapeutics, and Uvax Bio.
STAT
FEBRUARY 22, 2024
What do CEOs owe the world? Did Humira break the system? And can you CRISPR a fetus? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. First, former Alnylam Pharmaceuticals CEO John Maraganore and STAT’s Matthew Herper join us to discuss the legacy of AbbVie chief executive Richard Gonzalez, who announced his retirement this week.
Drug Store News
FEBRUARY 22, 2024
Walgreens-backed VillageMD is closing all its medical clinics in Florida, one of its biggest markets, per a Business Insider report.
Fierce Pharma
FEBRUARY 22, 2024
To get a pulse on Moderna following its “year of transition” in 2023, look no further than the company’s manufacturing operations. | To get a pulse on Moderna following its “year of transition” in 2023, look no further than the company’s manufacturing operations. The Cambridge, Massachusetts-based biotech has incurred a COVID-related wind-down charge on one hand, while it spends millions of dollars to bolster cancer vaccines at the same time.
pharmaphorum
FEBRUARY 22, 2024
More digital health consolidation as Aptar buys Healint, a specialist in patient support apps and software to run virtual clinical trials and patient registries
Pharmaceutical Commerce
FEBRUARY 22, 2024
A cohort study investigates how a change in clinical guidelines, an expanded label, and reduction in drug prices can impact the use of PCSK9 inhibitors as a treatment for atherosclerotic cardiovascular disease.
Expert insights. Personalized for you.
185 
Let's personalize your content